C07C 217/30
Having the oxygen atom of at least one of the etherified hydroxy
Official title: having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
C07C217/30 (Having the oxygen atom of at least one of the etherified hydroxy) appears on 122 US grants and 103 published applications in this corpus.
Search patents in C07C- Granted patents
- 122
- Published applications
- 103
- Assignees
- 89
- Inventors
- 411
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 7 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 8 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 4 | 9 |
| 2003 | 7 | 9 |
| 2004 | 3 | 7 |
| 2005 | 4 | 11 |
| 2006 | 6 | 9 |
| 2007 | 5 | 4 |
| 2008 | 5 | 3 |
| 2009 | 5 | 5 |
| 2010 | 2 | 4 |
| 2011 | 1 | 4 |
| 2012 | 0 | 2 |
| 2013 | 2 | 2 |
| 2014 | 2 | 4 |
| 2015 | 3 | 5 |
| 2016 | 4 | 3 |
| 2017 | 2 | 4 |
| 2018 | 3 | 2 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 3 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 5 | 3 |
| 2025 | 1 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same30 Sep 2025US 12,427,346 B2Autotac Inc.
- AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same29 Oct 2024US 12,129,218 B2Autotac Inc.
- Store overload-induced calcium release inhibitors and methods for producing and using the same17 Sep 2024US 12,091,408 B2UTI Limited Partnership
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same14 May 2024US 11,981,618 B2Autotac Inc.
- 1-(butyl(2-hydroxy-3-(naphthalen-1-yloxy)propyl)amino)-3-(naphthalen-2-yloxy)propan-2-ol as an eco-friendly insecticidal agent against Spodoptera littoralis (boisd.)20 Feb 2024US 11,903,385 B1King Faisal University
- Methods for producing viloxazine salts and novel polymorphs thereof8 Jan 2026US 2026/0008759 A1Supernus Pharmaceuticals, Inc.
- Anti-tumor compounds and methods of use thereof and synthesis thereof31 Jul 2025US 2025/0241876 A1Atossa Therapeutics, Inc.
- Salt of a pharmaceutical compound17 Jul 2025US 2025/0228799 A1Actimed Therapeutics Limited
- Composition, substrate treatment method, manufacturing method of semiconductor device, and compound3 Jul 2025US 2025/0215126 A1FUJIFILM Corporation
- Antibacterial composition17 Apr 2025US 2025/0120944 A1Seoul National University R&Db Foundation
Most cited
By later US patents
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996
- Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions103US 5,614,548 AWake Forest University · 1997
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Serotonin antagonists67US 5,013,761 AEli Lilly and Company · 1991
- Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them34US 5,254,595 AElf Sanofi · 1993